Drugs / Fresh Frozen Plasma (FFP)
Fresh Frozen Plasma (FFP)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT04109144 | Nov 2019 → Jul 2023 | cirrhosis of liver | Montefiore Medical Center | Withdrawn | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02557672 Comparator | Aug 2016 → Jun 2021 | hemorrhagic disease | Mayo Clinic | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fresh Frozen Plasma (FFP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04109144 ↗ |
| Modality | Protein / enzyme biologic | “Biological: Fresh frozen plasma (FFP)” NCT02557672 ↗ |
| Route | Intravenous | “At the second drainage participants will receive 2 units, or about 500 ccs, of fresh frozen plasma intravenously, plus 1 bottle, or 50 ccs, of 25% albumin if more than 4 liters...” NCT04109144 ↗ |